Urica Therapeutics, Inc. — Form D

Urica Therapeutics, Inc. of BAY HARBOR ISLANDS, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-05. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-01-05
• Form: D
• Accession: 0001959861-23-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $2.5M
• Remaining: $2.5M
• Investors: 26
• Date of first sale: 2022-12-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-469777

Issuer

• Name: Urica Therapeutics, Inc.
• CIK: 0001959861
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1111 KANE CONCOURSE, BAY HARBOR ISLANDS, FL, 33154
• Phone: 781-652-4500

Officers, directors & promoters (7)

More

• CIK 1959861 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search